Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
2019 · Trials · 64 citations
https://doi.org/10.1186/s13063-018-3158-6
Ottawa Hospital(CA)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
77
Papers
1.9K
Citations
24
h-index
39
i10-index
Michael Dürr is an academic researcher from Ottawa Hospital. The author has contributed to research in topics: Renal Transplantation Outcomes and Treatments & Organ Transplantation Techniques and Outcomes & Cytomegalovirus and herpesvirus research. The author has an h-index of 24, co-authored 66 publications.
ORCID: 0000-0003-1432-421Xhttps://doi.org/10.1186/s13063-018-3158-6
https://doi.org/10.1038/s41598-025-89122-w
Click to start Chat